BCG
CYTK icon

Breakwater Capital Group’s Cytokinetics CYTK Stock Holding History

Breakwater Capital Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$260K Hold
3,941
– – 0.03% 339
2026
Q2 		$336K Hold
3,941
– – 0.04% 292
2026
Q1 		$260K Hold
3,941
– – 0.03% 322
2025
Q4 		$250K Buy
3,941
+2
+0.1% +$124 0.03% 309
2025
Q3 		$216K Buy
+3,939
New +$162K 0.03% 334

Other funds holding CYTK

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Breakwater Capital Group's CYTK Position: Q3 2026 in Review

Breakwater Capital Group held its Cytokinetics (CYTK) position steady in Q3 2026 at 3,941 shares worth $260K. The position accounts for 0.03% of the portfolio, ranked #339.

Breakwater Capital Group first reported a position in CYTK in Q3 2025 and has held it in 5 quarters since. The position peaked at $336K in Q2 2026. 10 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Breakwater Capital Group held 3,941 shares of Cytokinetics worth $260K as of Q3 2026.
  • Breakwater Capital Group left its Cytokinetics share count unchanged in Q3 2026.
  • Cytokinetics made up 0.03% of Breakwater Capital Group's portfolio in Q3 2026, its #339 holding.
  • Breakwater Capital Group first reported a position in Cytokinetics in Q3 2025 and has held it in 5 quarters since.
  • Breakwater Capital Group's Cytokinetics position peaked at $336K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Breakwater Capital Group's 13F filing for Q3 2026, filed 9 Oct 2026.